Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Psoriatic Arthritis Treatment Strategy With Apremilast
2018-000335-27Phase 2Completed
- Sponsor
- Universitätsklinikum Erlangen
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of apremilast in plaque psoriasis, sponsored by Universitätsklinikum Erlangen. Primary endpoint: Change in osteophyte volume at second MCP joint. Started Jul 2018; status: completed.
02
Drugs
apremilast
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2018-000335-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000335-27.